Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Different deposit methods carry different fees. This overview helps you compare options and select the most cost-effective method.
20,384 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
American Express faced a notable decline as the market wrestled with AI fears and rate-cut speculation. This article ...
Public backlash can move beyond headlines and into wallets. This in-depth look examines the financial ripple effects ...
Micron Technology has surged about 330% in the past year as AI workloads tighten memory supply. With DRAM pricing lik...
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
Looking at how applied optoelectronics (aaoi) earnings shape the stock story? This guide breaks down what to watch in...
A new round of Iranian strikes tests the region’s missile defenses and buoyed defense stocks, while households weigh ...
Nvidia has built a fortress around AI-driven growth, but one number could alter the trajectory. This article breaks d...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...